Atai Life Stock Analysis

ATAI -  USA Stock  

USD 5.26  0.29  5.23%

The big decline in price over the last few months for Atai Life Sciences could raise concerns from stockholders as the firm it trading at a share price of 5.26 on 697,400 in volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Atai Life Sciences or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.22. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Atai Life partners.
Please continue to Trending Equities.

Atai Life Stock Analysis 

The Atai Life stock analysis report makes it easy to digest most publicly released information about Atai Life and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Atai Life Stock analysis module also helps to analyze the Atai Life price relationship with some important fundamental indicators such as market cap and management efficiency.

Atai Life Stock Analysis Notes

About 26.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atai Life Sciences recorded a loss per share of 3.94. The entity next dividend is scheduled to be issued on the 27th of August 2018. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 35 people. For more info on Atai Life Sciences please contact Xiaofeng Ma at 49 89 2153 9035 or go to

Atai Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Atai Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Atai Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Atai Life Sciences generated a negative expected return over the last 90 days
Atai Life Sciences has high historical volatility and very poor performance
Atai Life Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 20.15 M. Net Loss for the year was (165.52 M) with loss before overhead, payroll, taxes, and interest of (2.91 M).
Atai Life Sciences currently holds about 430.31 M in cash with (48.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68.
Atai Life Sciences has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Atai Life exotic insider transaction detected

Atai Life Sciences Upcoming and Recent Events

Earnings reports are used by Atai Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Atai Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of February 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End21st of February 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Atai Life Largest EPS Surprises

Earnings surprises can significantly impact Atai Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Atai Life SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Atai Life prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Atai Life investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Atai Life Sciences specific information freely available to individual and institutional investors to make a timely investment decision.
15th of December 2021
Financial Statements and Exhibits. Regulation FD Disclosure
1st of December 2021
Unclassified Corporate Event
29th of November 2021
Unclassified Corporate Event
15th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
16th of August 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
11th of August 2021
Financial Statements and Exhibits. Regulation FD Disclosure
13th of July 2021
Financial Statements and Exhibits. Regulation FD Disclosure
24th of May 2021
Unclassified Corporate Event

Atai Life Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Atai Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atai Life Sciences backward and forwards among themselves. Atai Life's institutional investor refers to the entity that pools money to purchase Atai Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fny Investment Advisers LlcCommon Shares20 K152 K
Exchange Traded Concepts LlcCommon Shares549K
Falcon Edge Capital LpCommon Shares2.5 M37.5 M
Pura Vida Investments LlcCommon Shares1.3 M18 M
Morgan StanleyCommon Shares982.9 K14.5 M
Woodline Partners LpCommon Shares750 K11.1 M
Citadel Advisors LlcCommon Shares722.9 K10.7 M
Pura Vida Investments LlcPut Options651.5 K9.6 M
Note, although Atai Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Atai Life Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 894.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atai Life's market, we take the total number of its shares issued and multiply it by Atai Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Atai Life Profitablity

Atai Life's profitability indicators refer to fundamental financial ratios that showcase Atai Life's ability to generate income relative to its revenue or operating costs. If, let's say, Atai Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Atai Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Atai Life's profitability requires more research than a typical breakdown of Atai Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(1.76) (1.90) 
Return on Average Equity(2.04) (2.21) 
Return on Invested Capital(8.77) (9.46) 
Return on Sales 732.41  790.23 

Management Efficiency

The entity has return on total asset (ROA) of (0.0524) % which means that it has lost $0.0524 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.2481) %, meaning that it created substantial loss on money invested by shareholders. Atai Life management efficiency ratios could be used to measure how well atai life sciences manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Sales is estimated to increase to 790.23, while Return on Average Assets are projected to decrease to (1.90) . The current Assets Non Current is estimated to increase to about 13 M, while Total Assets are projected to decrease to roughly 117.8 M.
Last ReportedProjected for 2022
Book Value per Share 1.12  1.07 
Enterprise Value over EBIT(31.50) (32.33) 
Enterprise Value over EBITDA(0.17) (0.17) 
Price to Book Value 0.50  0.52 
Tangible Assets Book Value per Share 1.38  1.28 
Enterprise Value-16.6 M-17 M
Tangible Asset Value128.3 M117.8 M

Technical Drivers

As of the 23rd of January, Atai Life shows the risk adjusted performance of (0.17), and Mean Deviation of 4.26. Atai Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Atai Life Sciences, which can be compared to its rivals. Please confirm Atai Life Sciences jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Atai Life Sciences is priced correctly, providing market reflects its regular price of 5.26 per share. Given that Atai Life has jensen alpha of (1.33), we suggest you to validate Atai Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Atai Life Sciences Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Atai Life Sciences more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Atai Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atai Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atai Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Atai Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Atai Life Predictive Daily Indicators

Atai Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Atai Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Atai Life Forecast Models

Atai Life time-series forecasting models is one of many Atai Life's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Atai Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Atai Life Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Atai Life stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Atai Life shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Atai Life. By using and applying Atai Life Stock analysis, traders can create a robust methodology for identifying Atai Life entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin 0.08  0.09 
Gross Margin(1.96) (2.01) 
Profit Margin(0.99) (1.02) 
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 35 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Atai Life to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Piotroski F Score Now


Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module
Please continue to Trending Equities. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bond Directory
Find actively traded corporate debentures issued by US companies
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.